Thromb Haemost 2007; 98(04): 903-905
DOI: 10.1160/TH07-02-0084
Case Report
Schattauer GmbH

Fibrinogen Leipzig II (γ351Gly→Ser and γ82Ala→Gly): Hypodysfibrinogenaemia due to two independent amino acid substitutions within the same polypeptide chain

Michael Meyer
1   Department of Biomedical Engineering and Biotechnology, University of Applied Sciences, Jena, Germany
,
Hermann Dietzel
2   Institute of Transfusion Medicine and Clinical Haemostasis, Hospital St. Georg, Leipzig, Germany
,
Ralph Kaetzel
2   Institute of Transfusion Medicine and Clinical Haemostasis, Hospital St. Georg, Leipzig, Germany
,
David Schmidt
1   Department of Biomedical Engineering and Biotechnology, University of Applied Sciences, Jena, Germany
,
Karin Liebscher
2   Institute of Transfusion Medicine and Clinical Haemostasis, Hospital St. Georg, Leipzig, Germany
,
Stephen O. Brennan
3   Molecular Pathology Laboratory, Canterbury Health Laboratories, Christchurch, New Zealand
› Author Affiliations
Further Information

Publication History

Received 04 February 2007

Accepted after resubmission 19 June 2007

Publication Date:
01 December 2017 (online)

 

 
  • References

  • 1 Maghzal GJ, Brennan SO, Homer VM. et al. The molecular mechanisms of congenital hypofibrinogenaemia.. Cell Mol Life Sci 2004; 61: 1427-1438.
  • 2 Asselta R, Duga S, Tenchini ML. The molecular basis of quantitative fibrinogen disorders.. J Thromb Haemost 2006; 4: 2115-2129.
  • 3 Database of fibrinogen variants. Available at: http://www.geht.org.
  • 4 Brennan SO, Fellowes AP, Faed JM. et al. Hypofibrinogenemia in an individual with two coding (γ82 A→G and BβP→L) and two noncoding mutations.. Blood 2000; 95: 1709-1713.
  • 5 Ivaskievicius V, Jusciute E, Steffens M. et al. γAla82Gly represents a common fibrinogen γ-chain variant in Caucasians.. Blood Coagul Fibrinol 2005; 16: 205-208.
  • 6 Wyatt J, Brennan SO, May S. et al. Hypofibrinogenaemia with compound heterozygosity for two γ chain mutations – γ82 Ala→Gly and an intron two GT→AT splice site mutation.. Thromb Haemost 2000; 84: 449-452.
  • 7 Meyer M, Franke K, Richter W. et al. New molecular defects in the γ subdomain of fibrinogen D-domain in four cases of (hypo)dysfibrinogenemia: fibrinogen variants Hannover VI, Homburg VII, Stuttgart and Suhl.. Thromb Haemost 2003; 89: 637-646.
  • 8 Hanss M, Ffrench P, Vinciguerra C. et al. Four cases of hypofibrinogenemia associated with four novel mutations.. J Thromb Haemost 2005; 3: 2347-2349.
  • 9 Steinmann C, Boegli C, Jungo M. et al. A new substitution, γ358 Ser→Cys, in fibrinogen Milano VII causes defective fibrin polymerisation.. Blood 1994; 84: 1874-1880.
  • 10 Mathonnet F, Guillon L, Detruit H. et al. Fibrinogen Poissy II (gammaN361K): a novel dysfibrinogenemia associated with defective polymerisation and peptide B release.. Blood Coagul Fibrinol 2003; 14: 293-298.